Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.27
-$0.10 (-2.97%)
At close: Sep 21, 2026, 4:00 PM ET
$3.27
$0 (0.00%)
Pre-market:
Sep 22, 2026, 7:04 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.15M | 2.15M | n/a | n/a | n/a | 2.34M | 4.59M | 4.59M | 4.59M | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -2.15M | -2.15M | n/a | n/a | n/a | -2.34M | -4.59M | -4.59M | -4.59M | -2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -191.64M | -215.87M | -231.75M | -250.48M | -267.66M | -270.22M | -273.21M | -273.79M | -269.8M | -264.84M | -259.66M | -265.46M | -258.52M | -243.97M | -224.34M | -199.6M | -190.75M | -170.59M | -167.25M | -182.15M | -159.9M | -149.41M |
Interest Income | 10.11M | 12.81M | 14.85M | 11.46M | 12.25M | 14.08M | 16.35M | 17.59M | 18.42M | 17.4M | 15.94M | 14.18M | 11.53M | 8.68M | 4.97M | 3.49M | 2.95M | 2.78M | 2.43M | 1.82M | 1.53M | 1.46M |
Pretax Income | -8.63M | -209.38M | -223.12M | -240.91M | -257.3M | -258.03M | -258.75M | -258.08M | -253.26M | -249.31M | -245.6M | -252.66M | -248.52M | -237.22M | -221.86M | -199.39M | -191.75M | -171.87M | -169.07M | -185.74M | -164.7M | -155.22M |
Net Income | -17.25M | -209.38M | -223.12M | -240.91M | -257.3M | -258.03M | -258.75M | -258.08M | -253.26M | -249.31M | -245.6M | -252.66M | -248.52M | -237.22M | -221.86M | -199.39M | -191.75M | -171.87M | -169.07M | -185.74M | -164.7M | -155.22M |
Selling & General & Admin | 67.52M | 75.11M | 86.5M | 97.15M | 105.91M | 107.47M | 100.39M | 96.59M | 88.06M | 78.86M | 73.32M | 70.83M | 67.35M | 62.83M | 58.77M | 51.9M | 46.82M | 43.49M | 42.63M | 38.66M | 34.36M | 31.67M |
Research & Development | 124.37M | 137.53M | 142.02M | 150.03M | 158.27M | 160.41M | 168.22M | 172.61M | 177.14M | 183.73M | 186.34M | 194.64M | 191.17M | 181.15M | 165.57M | 147.69M | 143.93M | 127.11M | 124.62M | 143.5M | 125.53M | 117.73M |
Other Expenses | -2.39M | 1.09M | 3.23M | 3.3M | 3.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 189.5M | 213.72M | 231.75M | 250.48M | 267.66M | 267.88M | 268.61M | 269.2M | 265.2M | 262.59M | 259.66M | 265.46M | 258.52M | 243.97M | 224.34M | 199.6M | 190.75M | 170.59M | 167.25M | 182.15M | 159.9M | 149.41M |
Interest Expense | 4.73M | 4.73M | 4.73M | 1.89M | 1.89M | 1.89M | 1.89M | 1.88M | 1.88M | 1.88M | 1.88M | 1.87M | 2.02M | 2.42M | 2.99M | 3.79M | 4.44M | 4.56M | 5.25M | 5.9M | 6.83M | 7.77M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -786K | -1.57M | -1.57M | -1.57M | -787K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 191.64M | 215.87M | 231.75M | 250.48M | 267.66M | 270.22M | 273.21M | 273.79M | 269.8M | 264.84M | 259.66M | 265.46M | 258.52M | 243.97M | 224.34M | 199.6M | 190.75M | 170.59M | 167.25M | 182.15M | 159.9M | 149.41M |
Income Tax Expense | 8.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 112.84M | 112.13M | 111.12M | 111.57M | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
Shares Outstanding (Diluted) | 114.51M | 112.13M | 111.12M | 111.57M | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
EPS (Basic) | -0.16 | -1.87 | -2.01 | -2.25 | -2.51 | -2.63 | -2.73 | -2.75 | -2.79 | -2.87 | -2.90 | -3.14 | -3.25 | -3.26 | -3.24 | -3.05 | -2.98 | -2.70 | -2.68 | -3.09 | -2.83 | -2.73 |
EPS (Diluted) | -0.17 | -1.87 | -2.01 | -2.25 | -2.51 | -2.63 | -2.73 | -2.75 | -2.79 | -2.87 | -2.90 | -3.14 | -3.25 | -3.26 | -3.24 | -3.05 | -2.98 | -2.70 | -2.68 | -3.09 | -2.83 | -2.73 |
EBITDA | 7.95M | -194.47M | -207.37M | -227.85M | -245.09M | -246.06M | -247.52M | -247.28M | -243.09M | -239.76M | -236.62M | -243.32M | -239.17M | -227.64M | -212.08M | -187.93M | -180.44M | -161.31M | -157.81M | -176.38M | -154.95M | -145.11M |
EBIT | -3.9M | -204.66M | -218.4M | -239.02M | -255.41M | -256.14M | -256.86M | -256.2M | -251.38M | -247.44M | -243.72M | -251.87M | -247.57M | -235.88M | -219.95M | -195.6M | -187.31M | -167.31M | -163.18M | -179.2M | -157.23M | -146.81M |
Depreciation & Amortization | 11.85M | 10.18M | 11.03M | 11.17M | 10.32M | 10.08M | 9.34M | 8.92M | 8.29M | 7.68M | 7.1M | 8.55M | 8.41M | 8.24M | 7.87M | 7.67M | 6.86M | 6M | 5.37M | 2.82M | 2.28M | 1.7M |
Add to Watchlist
Select watchlists to add or remove RCKT